Aibili Logo Association for Innovation and Biomedical Research on Light

AIBILI - Association for Innovation and Biomedical Research on Light and Image is a Research Technology Organisation in the health area dedicated to the development and clinical research of new products for medical therapy and diagnostic imaging.

It is a private non-profit organisation, founded in 1989, established to support translational research and technology transfer in the health area.

AIBILI is certified by ISO 9001 since 2004. It is certified for the following activities: performance of clinical studies; planning, coordination, monitoring of clinical research activities; health technology assessment; grading of eye exams; research and development in new technologies for medicine in the areas of imaging, optics and photobiology; preclinical studies of new molecules with potential medical use; and data centre activities.

AIBILI has the ECRIN Data Centre Certification, meeting the ECRIN requirements for IT and Data Management within clinical trials.

Clinical trials are performed in accordance with ICH Guidelines for Good Clinical Practice (GCP), European and national applicable legislations and regulations.


23 Feb 2017
Workshop on Clinical Research

AIBILI will organize a workshop dedicated to Clinical Research - Supporting Structures and Networks. The workshop is taking place on 23/02/2017 at 10:00. Please download here the programme.

31 Jan 2017
Pharmacovigilance: Updates on drug safety – quarterly publication; Vol. 3, Nº 4 // Farmacovigilância: Atualizações de segurança de medicamentos – Vol. 3, Nº 4

Pharmacovigilance: Updates on drug safety is a quarterly publication issued by the Portuguese Central Regional Pharmacovigilance Unit (UFC) delivering to patients and healthcare professionals information on the risks and safe use of medicines.

Farmacovigilância: Atualizações de segurança de medicamentos é uma publicação trimestral editada pela Unidade de Farmacovigilância do Centro (UFC) com o objetivo de disponibilizar informação de segurança dos medicamentos aos utentes e profissionais de saúde.

23 Nov 2016
AIBILI will coordinate an European Clinical Trial funded by IMI2

A Consortium led by the University of Bonn, in Germany, of which AIBILI is a Partner was awarded with an IMI2 grant of 16M€. [read more]


Copyright © 2017 AIBILI   -   Contact Us   -   Site Map   -   Webdesign Glitz Design   -   Programming Bizview